Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Revenue

Mankind Pharma had revenue of 35.70B INR in the quarter ending June 30, 2025, with 23.40% growth. This brings the company's revenue in the last twelve months to 129.10B, up 21.22% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.

• Revenue (ttm): 129.10B
• Revenue Growth: +21.22%
• P/S Ratio: 7.91
• Revenue / Employee: 4.79M
• Employees: 26,978
• Market Cap: 1,021.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	122.07B	19.47B	18.98%
Mar 31, 2024	102.60B	15.11B	17.27%
Mar 31, 2023	87.49B	9.68B	12.44%
Mar 31, 2022	77.82B	15.67B	25.22%
Mar 31, 2021	62.14B	3.43B	5.83%